New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
12:23 EDTCOV, SCTY, ORCL, MDT, NFLX, MCRS, ACOR, TSLA, EWOn The Fly: Midday Wrap
Stocks on Wall Street were slightly higher at midday after spending the morning fluctuating between narrow losses and marginal gains. The averages are drifting back and forth across the flat line as investors await the conclusion of the Fed's latest rate setting meeting, which kicked off today. ECONOMIC EVENTS: In the U.S., the consumer price index rose 0.4% in May, which was above the consensus forecast for an increase of 0.2%. Housing starts in the month declined 6.5% to a rate of about 1M and building permits slid 6.4% to a rate of 991K, which were both lower than expected. The Federal Reserve began its FOMC meeting, which will conclude tomorrow. COMPANY NEWS: Shares of register system and hospitality software maker Micros Systems (MCRS) surged 18% higher following a report from Bloomberg that the company is in talks to be acquired by tech giant Oracle (ORCL) for "more than" $5B... Shares of Edwards Lifesciences (EW) advanced nearly 5% after the company announced last night that it has received FDA approval for its SAPIEN XT transcatheter aortic heart valve for the treatment of certain high-risk and inoperable cardiovascular patients. Wells Fargo thinks the broad label and range of sizes approved by the FDA are a positive development for the company, while analysts at Canaccord noted that they view Edwards as an attractive acquisition candidate. Yesterday, CRT Capital said that it believes Medtronic's (MDT) acquisition of Covidien (COV) may signal an increase in sector M&A. MAJOR MOVERS: Among the notable gainers was SolarCity (SCTY), which jumped more than 15% after the solar energy system installer agreed to acquire solar panel technology and manufacturing company Silevo for up to $350M dollars. Also rising were shares of another company where Elon Musk is Chairman of the Board, Tesla Motors (TSLA), which rose over 3.5% after New Jersey's assembly approved a bill allowing the company to sell its cars directly in the state and New York Governor Andrew Cuomo signed a direct sales law in the neighboring state. Also higher was Netflix (NFLX), which rose 3% after Morgan Stanley upgraded the stock and research firm Pacific Crest issued a positive take on the shares in separate notes to investors earlier today. Among the noteworthy losers was executive recruiter Korn/Ferry (KFY), which dropped 3.5% after reporting on results during its just completed quarter and giving guidance for its current quarter. Also lower was Acorda Therapeutics (ACOR), which fell 5.5% after announcing an offering of $300M of convertible senior notes. INDEXES: Near midday, the Dow was up 9.46, or 0.06%, to 16,790.47, the Nasdaq was up 17.36, or 0.4%, to 4,338.46, and the S&P 500 was up 2.28, or 0.12%, to 1,940.06.
News For MCRS;ORCL;EW;NFLX;SCTY;TSLA;MDT;COV;ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
December 9, 2014
11:48 EDTTSLA, NFLXStocks with call strike movement; NFLX TSLA
Subscribe for More Information
11:29 EDTNFLXDiscovery CEO says international market 'steady, good' for company
Subscribe for More Information
10:32 EDTNFLXNetflix hits a fresh 6-month low, levels to watch
Subscribe for More Information
09:38 EDTTSLAActive equity options trading
Subscribe for More Information
08:07 EDTEWEdwards Lifesciences price target raised to $155 from $135 at JMP Securities
Subscribe for More Information
07:37 EDTTSLAUBS to hold a conference
Subscribe for More Information
07:36 EDTEWEdwards Lifesciences TAVI growth reinforces bullish stance, says Canaccord
Subscribe for More Information
07:35 EDTTSLATesla Motors volatility flat as shares trend lower
Tesla Motors December weekly call option implied volatility is at 48, December is at 42, January is at 39; compared to its 26-week average of 46 according to Track Data, suggesting non-directional price movement.
07:07 EDTEWEdwards price target raised to $151-$152 from $135-$140 at Wells Fargo
Wells Fargo increased its price target on Edwards Lifesciences as the firm believes that the company's roughly in-line 2015 guidance announced yesterday is conservative.The firm also notes that the company raised its long-term TAVR market assumption to over $3B in 2019. The firm keeps an Outperform rating on the shares.
06:48 EDTNFLXNetflix wants to be 'completely global' within five years, GigaOM reports
Netflix Chief Content Officer Ted Sarandos told investors at the UBS Global Media and Communications Conference that the company wants to be "completely global" and available everywhere in the world before 2020, GigaOM reports. CEO Reed Hastings has previously said that the company could eventually generate up to 80% of its revenue outside the U.S. Reference Link
December 8, 2014
16:00 EDTTSLAOptions Update; December 8, 2014
Subscribe for More Information
13:21 EDTTSLATesla has an active bearish pattern, levels to watch
Subscribe for More Information
11:29 EDTNFLXNetflix falls to session lows, levels to watch
The shares are down over 2% to $342.44. At that price next support is at $340.05. Resistance is at $345.45.
11:22 EDTTSLATesla estimated to sell 1,200 Model S in U.S. in November, InsideEVs says
Subscribe for More Information
10:00 EDTNFLXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:22 EDTTSLATesla weakness a buying opportunity, says RW Baird
Subscribe for More Information
08:16 EDTEWEdwards Lifesciences announces investments in CardioKinetix
Edwards made a structured investment in CardioKinetix, a privately held medical device company pioneering a catheter-based treatment for heart failure. This transaction increases Edwards' existing minority interest in CardioKinetix and provides an option to purchase the remaining outstanding shares for a future payment, plus additional milestone payments based on future regulatory and reimbursement approvals. In the second investment, the company acquired intellectual property that broadens its transcatheter mitral valve development efforts. Additional details of both investments were not disclosed.
08:15 EDTEWEdwards Lifesciences sees FY15 EPS $3.90-$4.10, consensus $3.96
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences backs FY14 EPS $3.33-$3.39, consensus $3.39
Subscribe for More Information
06:05 EDTEWEdwards Lifesciences to host investor meeting
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use